| Stability‐indicating RP‐HPLC method development and validation for determination of nine impurities in apixaban tablet dosage forms. Robustness study by quality by design approach VB Subramanian, NK Katari, T Dongala, SB Jonnalagadda Biomedical Chromatography 34 (1), e4719, 2020 | 44 | 2020 |
| Eco-friendly and green chromatographic method for the simultaneous determination of chlorocresol and betamethasone dipropionate in topical formulations using Box–Behnken design SK Muchakayala, NK Katari, T Dongala, VM Marisetti, G Vyas, ... Journal of the Iranian Chemical Society 19 (4), 1397-1412, 2022 | 38 | 2022 |
| QbD based development of HPLC method for simultaneous quantification of Telmisartan and Hydrochlorothiazide impurities in tablets dosage form AK Palakurthi, T Dongala, LNR Katakam Practical Laboratory Medicine 21, e00169, 2020 | 38 | 2020 |
| Development and validation of a RP-UPLC method for the determination of betamethasone dipropionate impurities in topical formulations using a multivariate central composite design SK Muchakayala, K Pavithra, NK Katari, VM Marisetti, T Dongala, ... Analytical Methods 13 (33), 3705-3723, 2021 | 33 | 2021 |
| Development and validation of a generic RP‐HPLC PDA method for the simultaneous separation and quantification of active ingredients in cold and cough medicines T Dongala, NK Katari, AK Palakurthi, SB Jonnalagadda Biomedical Chromatography 33 (11), e4641, 2019 | 31 | 2019 |
| Novel stability indicating UHPLC method development and validation for simultaneous quantification of hydrocortisone acetate, pramoxine hydrochloride, potassium sorbate and … LNR Katakam, T Dongala, SK Ettaboina Talanta Open 1, 100004, 2020 | 27 | 2020 |
| Stability‐indicating HPLC method for simultaneous quantification of 14 impurities in excedrin tablet formulations and identification of new impurity by LC–MS in accelerated … T Dongala, NK Katari, AK Palakurthi, SB Jonnalagadda Biomedical Chromatography 33 (10), e4608, 2019 | 26 | 2019 |
| RP-HPLC stability indicating method development and validation of pseudoephedrine sulfate and related organic impurities in tablet dosage forms, robustness by QbD approach T Dongala, LNR Katakam, AK Palakurthi, NK Katari Analytical Chemistry Letters 9 (5), 697-710, 2019 | 24 | 2019 |
| A simple and rapid HPLC method for determination of parabens and their degradation products in pharmaceutical dosage forms LNR Katakam, SK Ettaboina, T Dongala Biomedical Chromatography 35 (10), e5152, 2021 | 23 | 2021 |
| In vitro Dissolution Profile at Different Biological pH Conditions of Hydroxychloroquine Sulfate Tablets Is Available for the Treatment of COVID-19 T Dongala, NK Katari, SK Ettaboina, A Krishnan, MM Tambuwala, K Dua Frontiers in Molecular Biosciences 7, 613393, 2021 | 22 | 2021 |
| A novel UPLC-PDA isocratic method for the quantification fulvestrant in oil-based pre-filled syringe injection matrix formulations T Dongala, AK Palakurthi, Y Vytla, NK Katari Journal of Analytical Science and Technology 10, 1-12, 2019 | 22 | 2019 |
| Stability‐indicating reversed‐phase‐HPLC method development and validation for sacubitril/valsartan complex in the presence of impurities and degradation products: Robustness … VB Subramanian, NK Katari, V Ponnam, N Konduru, T Dongala, ... Biomedical Chromatography 36 (1), e5240, 2022 | 21 | 2022 |
| Quality by design with design of experiments approach for development of a stability‐indicating LC method for enzalutamide and its impurities in soft gel dosage formulation LNR Katakam, T Dongala, SK Ettaboina Biomedical Chromatography 35 (5), e5062, 2021 | 21 | 2021 |
| A simple high‐performance liquid chromatography method development for carbidopa and levodopa impurities: Evaluation of risk assessment before method validation by quality by … VB Subramanian, N Konduru, NK Katari, T Dongala, R Gundla Separation Science Plus 3 (11-12), 530-539, 2020 | 21 | 2020 |
| Stability indicating LC method development for hydroxychloroquine sulfate impurities as available for treatment of COVID-19 and evaluation of risk assessment prior to method … T Dongala, NK Katari, AK Palakurthi, LNR Katakam, VM Marisetti Chromatographia 83 (10), 1269-1281, 2020 | 21 | 2020 |
| Development and validation of a stability-indicating RP-HPLC method for the determination of erythromycin related impurities in topical dosage form SK Ettaboina, LNR Katakam, T Dongala Pharmaceutical Chemistry Journal 56 (1), 131-137, 2022 | 20 | 2022 |
| Quality by design with design of experiments approach for the development of a stability‐indicating LC method for benzonatate and its impurities in liquid oral dosage form LNR Katakam, T Dongala Separation science plus 3 (7), 276-285, 2020 | 17 | 2020 |
| A novel RP‐HPLC refractive index detector method development and validation for determination of trace‐level alcohols (un‐sulfated) in sodium lauryl sulfate raw material LNR Katakam, T Dongala Biomedical chromatography 34 (7), e4827, 2020 | 16 | 2020 |
| Development and validation of liquid chromatography method for determination of Ibrutinib in finished dosage forms using quality by design approach N Konduru, R Gundla, T Dongala, NK Katari, R Mallavarapu Separation Science Plus 5 (7), 254-266, 2022 | 15 | 2022 |
| QbD‐based development of an extraction procedure for simultaneous quantification of telmisartan, amlodipine besylate and chlorthalidone in combination complex matrix formulation AK Palakurthi, T Dongala, RK Yalavarthi, J Anireddy Biomedical chromatography 34 (2), e4755, 2020 | 14 | 2020 |
